Skip to main content

Webinars

Live and recorded scientific educational resources presented by industry thought leaders.

  • Lance Mikus ,
    MBA, Director of Product Management - Image Capture Systems at Leica Biosystems

In this webinar, the possible clinical applications of a range of multiplexing techniques and panels will be discussed, including potential methods for analyzing the resulting complex images.

  • Prof Dr. Francesca Bosisio ,
    Assistant Professor, University of Leuven (KU Leuven), Department of Imaging & Pathology, Translational Cell & Tissue Research
  • Asier Antoranz ,
    Post Doc Bioinformatician, University of Leuven (KU Leuven), Department of Imaging & Pathology, Translational Cell & Tissue Research

In this webinar, Prof. Francesca Bosisio and Asier Antoranz, assistant professor and post doc bioinformatician at University of Leuven, provide a practical example of what digital pathology can achieve, illustrating how high-dimensional single-cell multiplex analysis using multiple iterative labelling by antibody neodeposition (the MILAN technique) can characterize the immune landscape in primary melanoma.

  • Dr. Dana Adel Mustafa ,
    Assistant Professor & Group leader of the Tumor Immuno-Pathology (TIP) LaboratoryErasmus University Medical Centre, Department Pathology

In this webinar, Dr. Dana Adel Mustafa, shares how using the GeoMx Digital Spatial Profiler (DSP) to measure PDAC tissue samples can reveal the key immune-related players that drive survival in PDAC patients.

In this webinar, we will demonstrate how RNAscope technology can be used to detect viral infection and pathogenesis for research, and enhance our understanding of globally important viruses, such as SARS-CoV-2. For research labs that require high throughput and automated RNA in situ hybridization (ISH) technology on BOND RX, Bio-Techne has partnered with Leica Biosystems to deliver RNAscope® ISH automated assays.

  • Alexander David Borowsky ,
    MD, Professor, Pathology and Laboratory Medicine, Center for Immunology and Infectious Disease and UC Davis Comprehensive Cancer Center

Cancer initiation and virulence depends on mechanisms to evade host immunosurveillance and suppression of early invasion and growth.  Distinct phenotypes of the immune infiltrates in and around cancers derive from differing mechanisms. 

Understanding the tumor microenvironment (TME) is essential for the development of effective treatments for cancer patients. Traditional multiplex IHC methods offer limited understanding of the complex TME. This is partially due to technical limitations of chromogenic dyes and fluorescent detection systems. 

  • Michael Bates ,
    MD, Oncology Strategy, Medical and Scientific Affairs, Cepheid, Sunnyvale, California, USA

Learning Objectives of this webinar are History of Immuno-Oncology, Types of Immunotherapy, Immune Checkpoint Biomarker.

  • Caitriona Lyons ,
    PhD. Product Manager, Image Analysis, Leica Biosystems, Dublin, Ireland

Learning Objectives of this webinar are History of Immuno-Oncology, Types of Immunotherapy, Immune Checkpoint Biomarker.

Objectives of this webinar are monoplex vs Multiplex staining, Multiplexing in research including biopharma and drug  development and Pathways to clinical implementation.